Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.
Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback